Electromedical & Electrotherapeutic Apparatus · SIC 3845

Electromed, Inc.

ELMD

Watch

Latest revenue

$18.6M

as of 2026-03-31

Latest net income

$3.0M

as of 2026-03-31

Net margin

16.2%

as of 2026-03-31

Price · 5Y

+31.2% / yr 17.5 pts / yr vs S&P 500 287.6% total
Compare:

Live market

delayed ≤15 min
$38.22
0.93%
Market cap
$316.5M
Enterprise value
$316.5M
P/E (trailing)
42.0×
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$39.65
52-wk low
$17.73
Beta
Shares out
8.3M

5-year trend

What this company does

AI

Item 1. Business. Overview Electromed, Inc. (“we,” “our,” “us,” “Electromed” or the “Company”) develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest® Airway Clearance System (“SmartVest System”) to patients with compromised pulmonary function with a commitment to excellence and compassionate service. Our goal is to make High Frequency Chest Wall Oscillation (“HFCWO”) treatments as effective, convenient, and comfortable as possible, so our patients can breathe easier and live better with improved respiratory function and fewer exacerbations. We primarily employ a direct-to-patient and provider model, through which we…

AI summary unavailable — showing raw filing excerpt

Generated from ELMD's filing dated 2025-08-26

Key risks

AI

Item 1A. Risk Factors. As a smaller reporting company, we are not required to provide disclosure pursuant to this item.

AI summary unavailable — showing raw filing excerpt

Generated from ELMD's filing dated 2025-08-26

Profitability

Gross margin

78.1%

2.4%

Operating margin

15.1%

25.5%

Net margin

11.8%

25.1%

Return on equity

17.4%

50.9%

Return on assets

14.0%

42.1%

Leverage

Debt / equity

0.25×

42.0%

Debt / assets

19.7%

33.8%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$18.6M+18.4%$3.0M+58.8%16.2%

Q4 2025

2025-12-31

$18.9M+16.3%$2.8M+40.3%14.6%

Q3 2025

2025-09-30

$16.9M+15.1%$2.1M+44.9%12.6%

Q2 2025

2025-06-30

$17.4M+17.3%$2.2M+20.6%12.7%

Q1 2025

2025-03-31

$15.7M+13.1%$1.9M+26.7%12.1%

Q4 2024

2024-12-31

$16.3M+18.7%$2.0M+17.6%12.1%

Q3 2024

2024-09-30

$14.7M+19.0%$1.5M+851.0%10.0%

Q2 2024

2024-06-30

$14.8M$1.8M12.3%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Electromedical & Electrotherapeutic Apparatus · SIC 3845

No data yet for industry average

Your notes

Keep private notes on ELMD — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$0

Insider selling

$3.0M

Net activity

−$3.0M

Distinct insiders

2

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue
2026-05-15

Kathleen Skarvan

Director

Sale8,150$34.36$280.1K
2026-05-15

Kathleen Skarvan

Director

Sale19,032$35.24$670.7K
2026-05-15

Kathleen Skarvan

Director

Sale9,256$36.26$335.6K
2026-05-15

Kathleen Skarvan

Director

Sale3,562$37.33$133.0K
2025-09-11

Andrew Summers

Director

Sale3,153$24.42$77.0K
2025-09-10

Andrew Summers

Director

Sale39,378$23.68$932.4K
2025-09-10

Andrew Summers

Director

Sale16,203$25.16$407.7K
2025-09-10

Andrew Summers

Director

Sale6,576$25.94$170.6K
2025-09-10

Andrew Summers

Director

Sale404$26.62$10.8K

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns ELMD

Institutional value

$51.2M

Total shares held

2.6M

Distinct holders

61

-40 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1J.E. Simmons & Co., P.C.492.8K$11.5M+0 (+0.0%)No change
2BlackRock, Inc.458.8K$10.7M+11.9K (+2.7%)Added
3VANGUARD CAPITAL MANAGEMENT LLC335.0K$7.8MNew
4DIMENSIONAL FUND ADVISORS LP178.3K$4.2M-3.6K (-2.0%)Trimmed
5VANGUARD PORTFOLIO MANAGEMENT LLC78.3K$1.8MNew
6WHITE PINE CAPITAL LLC62.3K$1.5M+26.6K (+74.4%)Added
7VANGUARD FIDUCIARY TRUST CO47.6K$1.1MNew
8Bank of New York Mellon Corp44.3K$1.0M-3.5K (-7.4%)Trimmed
9BNP PARIBAS FINANCIAL MARKETS39.2K$916.5K+6.4K (+19.7%)Added
10Allspring Global Investments Holdings, LLC38.7K$906.3K-67.3K (-63.5%)Trimmed
11OAK RIDGE INVESTMENTS LLC38.2K$893.8KNew
12GLOBEFLEX CAPITAL L P35.1K$822.4K+0 (+0.0%)No change
13North Star Investment Management Corp.34.0K$795.9KNew
14Walleye Capital LLC31.7K$741.5KNew
15LOS ANGELES CAPITAL MANAGEMENT LLC27.3K$640.2K+4.0K (+17.2%)Added
16JPMORGAN CHASE & CO25.5K$621.0K-25.7K (-50.2%)Trimmed
17JANE STREET GROUP, LLC24.5K$573.6KNew
18LPL Financial LLC20.1K$470.2K-2.5K (-11.0%)Trimmed
19STRS OHIO18.7K$437.8K+0 (+0.0%)No change
20Voya Investment Management LLC15.5K$362.3K+2.7K (+20.8%)Added

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once ELMD's latest filing finishes processing.